FMP
23andMe Holding Co.
MEUSW
NASDAQ
Inactive Equity
23andMe, Inc., a consumer genetics and research company, engages in developing a genetic database to unlock insights leading to the rapid discovery of new targets for drug development. It offers a crowdsourced platform that helps people to access, understand, and benefit from the human genome; access direct-to-consumer genetic testing; and give consumers personalized information about their genetic health risks, ancestry, and traits. The company was incorporated in 2006 and is based in Sunnyvale, California with an additional office in Mountain View, California.
1.38 USD
-0.13 (-9.42%)
Valuation Date:
Dec 31, 1969 7:00 PM
Share Price on Valuation Date
$1.38
Stock Beta
0
Shares Outstanding
0